Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome

被引：0
|
作者：
Xialei Zheng
Junmi Lu
Shaojun Xiang
Pu Zou
Hao Chen
Jing Liu
Cheng Zeng
Yuhu He
机构：
[1] The Second Xiangya Hospital,Department of Cardiology
[2] Central South University,Department of Pathology
[3] The Second Xiangya Hospital,Department of Cardiology
[4] Central South University,Department of Cardiology
[5] Hong Jiang Hospital of Traditional Chinese Medicine,undefined
[6] The Second Affiliated Hospital of University of South China,undefined
来源：
Acta Diabetologica | 2024年 / 61卷
关键词：
LECT2; Metabolic syndrome; Inflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：643 / 655
页数：12
相关论文
共 50 条
  • [1] Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome
    Zheng, Xialei
    Lu, Junmi
    Xiang, Shaojun
    Zou, Pu
    Chen, Hao
    Liu, Jing
    Zeng, Cheng
    He, Yuhu
    ACTA DIABETOLOGICA, 2024, 61 (05) : 643 - 655
  • [2] Serum leukocyte cell-derived chemotaxin 2 level is associated with atopic dermatitis patients
    Zhao, Keyu
    Xu, Feng
    Jiang, Xinyu
    Chen, Jiong
    Zhu, Xiaoxia
    Zhou, Qiongyan
    Xu, Suling
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 11006 - 11012
  • [3] Serum Leukocyte Cell-Derived Chemotaxin 2 (LECT2) Level Is Associated with Osteoporosis
    Wang, Qiang
    Xu, Feng
    Chen, Jiong
    Xie, Yan-Qing
    Xu, Su-Ling
    He, Wen-Ming
    LABORATORY MEDICINE, 2023, 54 (01) : 106 - 111
  • [4] Reduced serum level of leukocyte cell-derived chemotaxin 2 is associated with the presence of diabetic retinopathy
    Okumura, Akinori
    Unoki-Kubota, Hiroyuki
    Yoshida-Hata, Natsuyo
    Yamamoto-Honda, Ritsuko
    Yamashita, Shigeo
    Iwata, Minoru
    Tobe, Kazuyuki
    Kajio, Hiroshi
    Noda, Mitsuhiko
    Katai, Naomichi
    Yamagoe, Satoshi
    Kaburagi, Yasushi
    CLINICA CHIMICA ACTA, 2016, 463 : 145 - 149
  • [5] Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis
    Yoo, Hye Jin
    Hwang, Soon Young
    Choi, Ju-Hee
    Lee, Hyun Jung
    Chung, Hye Soo
    Seo, Ji-A
    Kim, Sin Gon
    Kim, Nan Hee
    Baik, Sei Hyun
    Choi, Dong Seop
    Choi, Kyung Mook
    PLOS ONE, 2017, 12 (04):
  • [6] Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver
    Okumura, Akinori
    Unoki-Kubota, Hiroyuki
    Matsushita, Yumi
    Shiga, Tomoko
    Moriyoshi, Yuriko
    Yamagoe, Satoshi
    Kaburagi, Yasushi
    BIOSCIENCE TRENDS, 2013, 7 (06) : 276 - 283
  • [7] Incidental finding of leukocyte cell-derived chemotaxin 2-Associated amyloidosis in a liver
    Gibier, Jean-Baptiste
    Gilbertson, Janet A.
    Perbet, Romain
    Leriche, William
    Truant, Stephanie
    Leteurtre, Emmanuelle
    Gillmore, Julian D.
    Gnemmi, Viviane
    ANNALES DE PATHOLOGIE, 2020, 40 (06) : 472 - 477
  • [8] Leukocyte cell-derived chemotaxin 2 inhibits development of atherosclerosis in mice
    He, Wen-Ming
    Dai, Ting
    Chen, Jiong
    Wang, Jian-An
    ZOOLOGICAL RESEARCH, 2019, 40 (04) : 317 - 323
  • [9] Leukocyte cell-derived chemotaxin 2 is a zinc-binding protein
    Okumura, Akinori
    Suzuki, Takehiro
    Miyatake, Hideyuki
    Okabe, Tomoya
    Hashimoto, Yuki
    Miyakawa, Takuya
    Zheng, Hai
    Unoki-Kubota, Hiroyuki
    Ohno, Hideaki
    Dohmae, Naoshi
    Kaburagi, Yasushi
    Miyazaki, Yoshitsugu
    Tanokura, Masaru
    Yamagoe, Satoshi
    FEBS LETTERS, 2013, 587 (05) : 404 - 409
  • [10] Leukocyte cell-derived chemotaxin 2 inhibits development of atherosclerosis in mice
    Wen-Ming He
    Ting Dai
    Jiong Chen
    Jian-An Wang
    Zoological Research, 2019, 40 (04) : 317 - 323
12345